Inventor
ZHAO GUOHUA
US27 patents
⚠️ This page may combine multiple inventors who share the name “ZHAO GUOHUA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
23 patentsUS8791091B2Jul 29, 2014
Aryl dihydropyridinone and piperidinone MGAT2 inhibitors
BRISTOL MYERS SQUIBB CO18 citations92
US6642252B2Nov 4, 2003
Acid derivatives useful as serine protease inhibitors
BRISTOL MYERS SQUIBB CO31 citations92
US6344450B1Feb 5, 2002
Lactam compounds and their use as inhibitors of serine proteases and method
BRISTOL MYERS SQUIBB CO31 citations88
US9701672B2Jul 11, 2017
Dihydropyridinone MGAT2 inhibitors for use in the treatment of metabolic disorders
BRISTOL MYERS SQUIBB CO8 citations84
US7956049B2Jun 7, 2011
Melanin concentrating hormone receptor-1 antagonists
BRISTOL MYERS SQUIBB CO10 citations84
US7553836B2Jun 30, 2009
Melanin concentrating hormone receptor-1 antagonists
BRISTOL MYERS SQUIBB CO13 citations84
US9901572B2Feb 27, 2018
Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
BRISTOL MYERS SQUIBB CO6 citations83
US9663466B2May 30, 2017
Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
BRISTOL MYERS SQUIBB CO8 citations83
US9187424B1Nov 17, 2015
Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
BRISTOL MYERS SQUIBB CO10 citations83
US9856244B2Jan 2, 2018
Dihydropyridinone MGAT2 inhibitors
BRISTOL MYERS SQUIBB CO2 citations73
US10695328B2Jun 30, 2020
Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
BRISTOL MYERS SQUIBB CO2 citations72
US10369140B2Aug 6, 2019
Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
BRISTOL MYERS SQUIBB CO3 citations72
US10968219B2Apr 6, 2021
3-substituted propionic acids as αV integrin inhibitors
BRISTOL MYERS SQUIBB CO2 citations68
US10966967B2Apr 6, 2021
Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
BRISTOL MYERS SQUIBB CO0 citations62
US11884661B2Jan 30, 2024
3-substituted propionic acids as αV integrin inhibitors
BRISTOL MYERS SQUIBB CO0 citations58
US11639353B2May 2, 2023
Cyclobutanes- and azetidine-containing mono and spirocyclic compounds as αV integrin inhibitors
BRISTOL MYERS SQUIBB CO0 citations58
US11014922B2May 25, 2021
Cyclobutane- and azetidine-containing mono and spirocyclic compounds as αV integrin inhibitors
BRISTOL MYERS SQUIBB CO0 citations58
US10717736B2Jul 21, 2020
Pyrrole amides as alpha V integrin inhibitors
BRISTOL MYERS SQUIBB CO1 citations56
US8344160B2Jan 1, 2013
Pyrrolone melanin concentrating hormone receptor-1 antagonists
BRISTOL MYERS SQUIBB CO2 citations56
US7812024B2Oct 12, 2010
Modulators of serotonin receptors
BRISTOL MYERS SQUIBB CO0 citations51
US11292802B2Apr 5, 2022
Substituted tetrahydropyrrolo[1,2-a]pyrazines as alpha v integrin inhibitors
BRISTOL MYERS SQUIBB CO0 citations46
US9586900B2Mar 7, 2017
Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists
BRISTOL MYERS SQUIBB CO0 citations42
US10730863B2Aug 4, 2020
Bridged bicyclic compounds as farnesoid X receptor modulators
BRISTOL MYERS SQUIBB CO0 citations38
KUNSHAN GOVISIONOX OPTOELECTRONICS CO LTD
3 patentsUS11100868B2Aug 24, 2021
Display devices, display panels and capacitance compensation method thereof
KUNSHAN GOVISIONOX OPTOELECTRONICS CO LTD2 citations71
US11114035B2Sep 7, 2021
Pixel circuit and display device
KUNSHAN GOVISIONOX OPTOELECTRONICS CO LTD0 citations58
US10902788B2Jan 26, 2021
Scan drivers, driving methods thereof and organic light emitting displays
KUNSHAN GOVISIONOX OPTOELECTRONICS CO LTD0 citations52